Recovery of hypothyroidism caused by immune checkpoint inhibitors after stopping treatment
Official title: SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
Run by Seoul National University Bundang Hospital · NCT07421869 · Data updated 2026-11-12
This trial will test whether adults who developed hypothyroidism while on immune checkpoint inhibitors can stop levothyroxine after those cancer drugs are stopped.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 107 (estimated) |
| Sponsor | Seoul National University Bundang Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Seongnam-si) |
| Status | Recruiting |
| Started | June 12, 2024 |
| Main results expected | March 4, 2029 |
| Study ends | March 4, 2029 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT07421869 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥19 years) who developed hypothyroidism while receiving ICIs, started levothyroxine, have already stopped ICI therapy, and are currently taking less than 0.1 mg levothyroxine are ideal candidates.
✕Probably not a fit
Patients with prior thyroid surgery, radioactive iodine or neck radiation, those still on high-dose levothyroxine (≥0.1 mg), or those still receiving ICIs are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls adults who developed hypothyroidism during immune checkpoint inhibitor (ICI) therapy, have discontinued ICIs, and are taking levothyroxine. Participants will undergo a stepwise levothyroxine taper every three months if thyroid function tests remain normal, with planned discontinuation if they maintain normal tests on a low dose (≤0.025 mg). Thyroid function tests and clinical symptoms will be monitored at each visit to detect recovery or relapse. The study will quantify the proportion of patients who can stop thyroid replacement and analyze clinical and laboratory factors that predict successful withdrawal.
Why it matters
Potential benefit: If successful, some patients may be able to stop long-term levothyroxine and avoid unnecessary lifelong thyroid replacement.
How similar studies have gone: Retrospective reports show that some patients recover thyroid function after stopping ICIs, but prospective, structured withdrawal data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 19 years or older. * Patients with a history of treatment with immune checkpoint inhibitors (ICIs). * Developed hypothyroidism during ICI treatment and initiated levothyroxine after starting ICI therapy. * Discontinued ICI therapy prior to study enrollment. Exclusion Criteria: * Use of levothyroxine or antithyroid medications within 3 months prior to initiating ICI therapy. * History of thyroid surgery, radioactive iodine therapy, or neck radiation therapy. * Current levothyroxine dose ≥0.1 mg at the time of enrollment.
Where it's running
-
Department of Internal Medicine, Seoul National University Bundang Hospital
Seongnam-si, South Korea Recruiting
Study contacts
- Study coordinator: Min Joo Kim, Professor
- Email: mjkim@snubh.org
- Phone: +82-31-787-7855
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
North Star desiccated porcine thyroid tablets for primary hypothyroidism
This phase 3, open-label study tests whether North Star desiccated porcine thyroid tablets can help people with primary hypothyroidism who are already taking a stable dose of LT4.
-
Can a smart wristband help guide levothyroxine dosing after total thyroidectomy
This study tests whether nighttime heart rate and rhythm data from a wearable can hint if levothyroxine dose is too high or too low before the usual blood tests.
-
Internal organ and muscle health in hypothyroidism
This study tests how hypothyroidism affects organ size and muscle strength in adults receiving routine care in Andijan, Uzbekistan.
-
Evaluating diagnostic and therapeutic strategies for thyroid conditions
This study is testing different ways to diagnose and treat thyroid problems, like hypothyroidism and thyroid cancer, to see which methods work best for patients.
-
Effects of Different Resistance Training on Quality of Life in Women with Hypothyroidism
This study is testing whether different types of strength training can improve the quality of life for women aged 35 to 45 who have hypothyroidism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.